Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 2 FEBRUARY
Publisherwww.maharshicharaka.in

A clinical study of Guru and Snigdha Guna of Kapha Dosha and its applied aspect in Yuvana Pidika w.s.r to Manjistha Ghan Vati and Arjunatvak Lepa

Daria P1*, Verma P2, Yadav CR3
DOI:10.21760/jaims.10.2.5

1* Priyanka Daria, Ayurved Medical Officer, Rajasthan Government, Rajasthan, India.

2 Priyanka Verma, PhD Scholar, PG Department of Rasa Shastra and Bhaishajya Kalpana, National Institute of Ayurveda, Deemed to be University (De-novo), Jaipur, Rajasthan, India.

3 Yadav CR, HOD and Professor, PG Department of Sharir Kriya, National Institute of Ayurveda, Deemed to be University (De-novo), Jaipur, Rajasthan, India.

Due to increased competition of earning prosperity in today era human adopted not only lifestyle but also food habits of western culture which is chiefly responsible to derangement in their physiology and responsible to number of skin disorder like Yuvana Pidika (acne vulgaris). Yuvana Pidika is one of them, which affects the beauty as well as personality. Acharya Sushruta and Yogaratnakar have mentioned it in the group of ‘Kshudra Roga’. Acharya Charak described Pidika in Raktapradoshaja Vikara. It occurs due to vitiation of Kapha Dosha, Vata Dosha and Rakta Dhatu. As per modern point of view under the influence of androgenic hormones sebaceous glands get hypertrophied and increase in production of sebum leads to onset of acne. For this Manjistha Ghan Vati and Arjunatvak Lepa were selected for the study on 30 registered patients. Namely group A, B and C. Each group has 10 patients. Group A: Arjunatvak Lepa with Godugdha (external application, as required once daily for 30 days). Group B: Manjistha Ghan Vati 500mg (2*250mg) twice daily for 30 days. Group C: Both Arjunatvak Lepa and Manjistha Ghan Vati were given daily for 30 days.

Keywords: Yuvana Pidika, Kapha Dosha, Manjistha Ghan Vati, Arjunatvak Lepa

Corresponding Author How to Cite this Article To Browse
Priyanka Daria, Ayurved Medical Officer, , Rajasthan Government, , Rajasthan, India.
Email:
Daria P, Verma P, Yadav CR, A clinical study of Guru and Snigdha Guna of Kapha Dosha and its applied aspect in Yuvana Pidika w.s.r to Manjistha Ghan Vati and Arjunatvak Lepa. J Ayu Int Med Sci. 2025;10(2):26-31.
Available From
https://jaims.in/jaims/article/view/4047

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-01-12 2025-01-22 2025-02-03 2025-02-13 2025-02-23
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Yes 12.52

© 2025by Daria P, Verma P, Yadav CRand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionAims and
Objectives
Materials and
Methods
Observation and
Results
DiscussionConclusionReferences

Introduction

In the present scenario of the people are very much conscious about their health as well as beauty and good looking.

A great philosopher says that human faces express and represent their personality and wisdom. It is saying that “Face is the index of mind”. An aphorism is “A thing of beauty is joy forever”. So, everyone and mostly youngsters are most cautious and careful about the beauty of face. This most important and beautiful organ is affected by certain anomalies of the adolescent age i.e. 16 - 30 years. Which are the wonder years of an individual’s life. They are more beauty conscious during this age.

Any minor ailment may affect from unattractive look to a permanent disfigurement which may result in inferiority complex Such a big effect is caused by disease Yuvana Pidika. Acharya Sushruta and Yogaratnakara have mentioned it in the group of ‘Kshudra Roga.[1,2] Acharya Charaka described Pidika in Raktapradoshaja Vikara. It occurs due to vitiation of Kapha Dosha, Vata Dosha and Rakta Dhatu.

According to Ayurveda, Dosha, Dhatu & Mala are the base of body.[3]

Principally Tridosha are the substances having specific Guna (quality) & Karma (functions). Yuvana Pidika is correlated to Acne vulgaris which is described in modern science. Acne vulgaris is a distressing condition which is related to the pilosebaceous follicles, is considered as an adolescent disorder.

Kapha in normal state is considered as strength of the body but in a vitiated form it produces so many diseases like Yuvana Pidika. In Yuvana Pidika, there is predominance of Kapha Dosha. So, it is necessary to study to develop the physiological study of Guru and Snigdha Guna of Kapha and its applied aspect in Yuvana Pidika.

According to the Global burden of disease (GBD) study, acne vulgaris effects 85% of young adults aged 12-25 years. Acne consistently represents the top three most prevalent skin conditions in the general population. Acne is the major problem at the age puberty. Topical antibiotic therapy is recommended for its treatment but their chemical compounds create adverse effects on the body,

So Natural Nontoxic remedies should be used to bring the skin into normal state by treating problem like Yuvana Pidika. Acharya Vagbhatta recommends Lepa as first line of treatment.

Lepa is beneficial in terms of its time duration, easy administration and cost effectiveness required for the treatment, during this current trend of busy schedule and fast life styles. So, the need of time is to find out an effective, potent and natural remedy to cure this disease.

In this study Arjunatvak Lepa[4] was selected as local application, and Manjishtha Ghana Vati as internal administration.

Aims and Objectives

1. Physiological study of Guru and Snigdha Guna of Kapha Dosha.
2. Clinical assessment of Guru and Snigdha Guna of Kapha Doshas.r. to Yuvana Pidika.
3. To evaluate the efficacy of Arjunatvak Lepa and Manjihstha Ghana Vati in Yuvana Pidika.

Materials and Methods

Selection of cases

30 patients were selected and registered in OPD of NIA and SSBH Jaipur.

Inclusion criteria

1. Age -16-30 year
2. Sex - Either sex
3. Patients complaining of Yuvana Pidika on over face.
4. Yuvana Pidika resembling with the features as explained in classics.
5. Patients willing to sign the consent form.

Exclusion criteria

1. With present history of chronic diseases e.g. psoriasis, dermatitis, vitiligo etc. related to face.
2. Patients having allergic history on Arjuna,
3. Patients suffering from other systemic diseases or organ failure.
4. Any kind of hereditary skin disorder.
5. Person suffering from any infective or contagious skin disease.

Duration of clinical trial and follow up:

30 days trial with follow up after 7 days.


Administration of drugs:

The therapeutic protocol in the present study includes 30 patients in 3 different groups, selected from OPD of NIA and SSBH hospital, Jaipur using randomized method of clinical trial. 10 patients were included in each group.

Group A: Arjunatvak Lepa application once daily for 30 days.

Group B: Manjistha Ghan Vati 500mg (2*250mg) twice daily for 30 days.

Group C: Both Arjunatvak Lepa and Manjistha Ghan Vati were given daily for 30 days.

Criteria of assessment:

During the trial the patients were assessed on the following parameters -

The effect of the management will be assessed on the basis of subjective and objective criteria.

Criteria for assessment of Yuvana Pidika:

Subjective parameters:

A. Pidika Sankhya

0 - No Pidika
1 - 1-5
2 - 6-10
3 - >10

B. Vivarnata (no. of scar)

0 - Absent
1 - 1-5
2 - 6-10
3 - >10

C. Kandu

0 - Absent
1 - Mild
2 - Moderate
3 - Severe

D. Sarva

0 - Absent
1 - Lasika
2 - Puya

E. Vedana of Pidika

0 - Absent
1 - Mild

2 - Moderate
3 - Severe

F. Daha

0 - Absent
1 - Mild
2 - Moderate
3 - Severe

G. Shotha

0 - Absent
1 - Mild
2 - Moderate
3 - Severe

Objective parameter (Moister meter test)

SNMoisture meter reading percentage
1.0 - 30
2.30.01 - 35
3.35.01 - 40
4.40.01 - 45
5.45.01 - 50
6.>50

Assessment of Guru Guna

1. Gauravata

0 - No heaviness in the body
1 - Feels heaviness in the body, but it does not hamper routine work
2 - Feels heaviness in the body which partially hamper daily routine work
3 - Feels heaviness in the body which badly hamper routine work

2. Sleeping Tendency

0 - Uninterrupted sound sleep/NREM
1 - Interrupted sleep
2 - Always feels sleepy and lethargies

3. Learning Capacity

0 - Quick
1 - Proper and in time
2 - Moderate
3 - Delayed

Assessment of Snigdha Guna

1. Oiliness of face

0 - Normal skin
1 - Face become oily 3-4 hrs. after wash
2 - Face become oily 1-2 hrs. after wash


3 - Requires face wash once in every half an hr.

2. Blotting paper test

0 - Look is dry with no oiliness
1 - Mild oily secretion felt by the patient, but not detected by blotting paper
2 - Mild oily secretion detected by 1blotting paper
3 - Oily secretion, collected by >1 blotting paper

3. Consistency of stool

0 - Normal form stool
1 - Semi solid stool
2 - Hard stool
3 - Pellets

Statistical presentation and analysis

All the signs and symptoms, before trial and after trial were compared and data were analyzed statistically.

Observation and Results

Most of the patients were 16-20 years of age. They complained mostly of Pidika, Kandu, Daha and oily skin.

Table 1: The effect of Arjunatvak Lepa on subjective parameters in Group A (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Pidikasankhya102.001.500.5025.000.530.170.0625NS
Vivarnata101.901.200.7036.840.480.150.0156S
Kandu102.001.300.7035.000.480.150.0156S
Sarva101.301.000.3023.080.480.150.2500NS
Vedna101.701.100.6035.290.520.160.0313S
Daha101.801.200.6033.330.520.160.0313S
Shotha102.001.300.7035.000.480.150.0156S

Table 2: The effect of Manjistha Ghan Vati on subjective parameters in Group B (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Pidikasankhya102.401.600.8033.330.420.130.0078VS
Vivarnata102.301.201.1047.830.570.180.0039VS
Kandu101.501.000.5033.330.530.170.0625NS
Sarva101.300.600.7053.850.670.210.0313S
Vedna101.500.800.7046.670.480.150.0156S
Daha101.601.100.5031.250.530.170.0625NS
Shotha101.600.900.7043.750.670.210.0313S

Table 3: The effect of both Arjunatvak Lepa and Manjistha Ghan Vati on subjective parameters in Group C (Wilcoxon matched pairs signed rank test).

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Pidikasankhya102.201.500.7031.820.480.150.0156S
Vivarnata102.201.300.9040.910.320.100.0039VS
Kandu102.201.500.7031.820.670.210.0313S
Sarva101.200.500.7058.330.480.150.0156S
Vedna101.800.801.0055.560.470.150.0039VS
Daha101.601.000.6037.500.520.160.0313S
Shotha102.101.001.1052.380.320.100.0020VS

Table 4: The effect of therapy on objective parameters (Moister meter) in Group A, B & C (Paired t test)

GroupNMeanDif.% of ChangeSDSEP valueR
BTAT
Group A1029.6928.691.003.370.770.240.0027VS
Group B1029.2629.220.040.140.050.020.0368S
Group C1031.7631.140.621.950.460.140.0020VS

Table 5: Showing Analysis of Guru Guna in Group A (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Gauravata102.201.500.7031.820.480.150.0156S
Sleeping Tendency101.300.600.7053.850.670.210.0313S
Learning Capacity102.201.800.4018.180.520.160.1250NS

Table 6: Showing Analysis of Guru Guna in Group B (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Gauravata101.901.100.8042.110.670.210.0156S
Sleeping Tendency101.301.000.3023.080.480.150.2500NS
Learning Capacity101.901.300.6031.580.520.160.0313S

Table 7: Showing Analysis of Guru Guna in Group C (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Gauravata101.800.900.9050.000.570.180.0078VS
Sleeping Tendency101.200.500.7058.330.630.200.0156S
Learning Capacity101.901.300.6031.580.520.160.0313S

Table 8: Showing Analysis of Snigdha Guna in Group a (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Oiliness of face101.801.000.8044.440.420.130.0078VS
Blotting paper test101.801.100.7038.890.480.150.0156S
Consistency of stool101.200.600.6050.000.520.160.0313S

Table 9: Showing Analysis of Snigdha Guna in Group B (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Oiliness of face101.600.800.8050.000.790.250.0313S
Blotting paper test101.800.801.0055.560.670.210.0078VS
Consistency of stool101.501.100.4026.670.520.160.1250NS

Table 10: Showing Analysis of Snigdha Guna in Group C (Wilcoxon matched pairs signed rank test)

SymptomsNMeanDif.% of ChangeSDSEP valueR
BTAT
Oiliness of face102.000.401.6080.000.700.220.0039VS
Blotting paper test101.900.801.1057.890.570.180.0039VS
Consistency of stool100.900.200.7077.780.670.210.0313S

Comparing the symptomatic improvement in all three groups, it was found that average percentage of relief was higher in Group C’ (44.04%) followed by ‘Group B’ (41.43%) and by ‘Group A’ (31.93%). It shows that effect of therapy was more in Group C in comparison to Group A and Group B.

Discussion

Yuvana Pidika is a common skin disorder which affects one’s beauty as well as personality. Yuvana Pidika is occurred by vitiation of Kapha Dosha, Vata Dosha and Rakta Dhatu.

Arjuna[5]

Arjuna possesses Kashaya Rasa, Laghu & Ruksha Guna, Sheeta Virya and Katu Vipaka.

  • Shoshana is the Karma of Kashaya Rasa, so it counteracts
  • Laghu Guna of Arjuna brings Vrana Ropana Karma and
  • Dahashamak is the Karma of Sheeta Virya. It mitigates Kapha due to its Kashya Rasa and Pitta due to its Sheeta Virya. Due to these properties, it reduces Shotha, Daha, and

Manjishtha[6]

Manjishtha possess Madhura, Tikta, & Kashaya Rasa, Guru & Ruksha Guna, Ushna Virya and Katu Vipaka.

  • Kshina Kshata Sandhankara is the Karma of Madhura Rasa. It improves wound healing, reduces Vranavastu (scar) and Daha (burning sensation).
  • Madhura Rasa is Shadhendriya Prasadaka, Twachya.
  • Tikta Rasa has property of Kleda Meda Upashoshana, Daha Shamaka, Kusthahara.
  • Shoshana is the Karma of Kashaya Rasa, so it counteracts
  • Usna Veerya is Vilayan Karaka, Pachaka and Kapaha-Vatahara.
  • Due to its Kaphahara properties, it reduces the Vaktra Mukha Snigdhata.
  • Due to the Pittashamak properties of Manjishtha, it pacifies the Daha produced due to Pitta. Because of Kapha-Pittahara properties of Manjishtha along with its Deepana action, it prevents the vitiation of Medogni resulting in eruption of a smaller number of

Conclusion

Group A (Arjunatvak Lepa) had significant effect on Vivarnata, Kandu, Vedana, Daha & Shotha while it was not significant on Pidikasankhya & Srava. Group B (Manjishtha Ghan Vati) had very significant effect on Pidikasankhya & Vivarnata, significant effect on Srava, Vedana, Shotha, while it was not significant on Kandu & Daha. Group C (Arjunatvak Lepa and Manjishtha Ghan Vati) had very significant effect on Vivarnata, Vedna and Shotha, while it was significant on Pidikasankhya, Kandu, Sarva & Daha. Comparing the symptomatic improvement in all three groups it was found that average percentage of relief was higher in Group C’ (44.04%) followed by ‘Group B’ (41.43%) and by ‘Group A’ (31.93%). It shows that effect of therapy was more significant in Group C in comparison to Group A and Group B.

References

1. Laksmipati Sastri. Yogaratnakara. 3rd reprint ed. Varanasi: Chaukhamba Publication; 2013. Chapter: Kshudra Rog Chikitsa, verse 4, p. 282 [Crossref][PubMed][Google Scholar]


2. Yadavji Trikamji. Sushruta Samhita, Nibandhasangrah. Vol. 1. 2nd reprint ed. Varanasi: Chaukhamba Surbharti Prakashan; 2003. Nidansthana, Chapter 13, verse 39, p. 3 [Crossref][PubMed][Google Scholar]

3. Yadavji Trikamji Acharya. Sushruta Samhita. Vol. 1. 2nd reprint ed. Varanasi: Chaukhamba Surbharti Prakashan; 2003. Sutrasthana, Chapter 15, verse 3, p. 67 [Crossref][PubMed][Google Scholar]

4. Laksmipati Sastri. Yogaratnakara. 3rd reprint ed. Varanasi: Chaukhamba Publication; 2013. Chapter: Kshudra Rog Chikitsa, verse 4, p. 282 [Crossref][PubMed][Google Scholar]

5. Sharma PV. Dravya Guna Vigyana. Vol. 2. 3rd reprint ed. Varanasi: Chaukhambha Bharti Publication; 2012. Chapter 3, p. 195 [Crossref][PubMed][Google Scholar]

6. Pandey G. Dravyaguna Vijnana. Vol. 2. 3rd reprint ed. Varanasi: Choukhamba Krishnadas Publication; 2005. Chapter 4, pp. 500–503 [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.